0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CAR-T Cell Service Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-23Q17918
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CAR T Cell Service Market Research Report 2024
BUY CHAPTERS

Global CAR-T Cell Service Market Research Report 2026

Code: QYRE-Auto-23Q17918
Report
2026-02-05
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CAR-T Cell Service Market Size

The global CAR-T Cell Service market was valued at US$ 1443 million in 2025 and is anticipated to reach US$ 2075 million by 2032, at a CAGR of 5.4% from 2026 to 2032.

CAR-T Cell Service Market

CAR-T Cell Service Market

CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
The CAR - T cell service industry is currently experiencing rapid development and faces many opportunities and challenges. Driven by the increasing incidence of cancer and the continuous advancement of technology, the industry has broad development prospects. Technologically, the research and development of new CAR - T cell technologies is accelerating. The industry is committed to improving the efficacy and safety of CAR - T cells in treating solid tumors, such as by adding controllable suicide genes and pro - inflammatory cytokines to the CAR structure. In addition, the exploration of CAR - T cell therapy in the treatment of autoimmune diseases has also become a hot topic, with many clinical trials ongoing. Commercially, there are currently 11 CAR - T cell therapy drugs approved globally, with sales continuing to increase. However, the high price of drugs and the narrow patient population limit the expansion of the market scale. Therefore, reducing costs and expanding the patient population are the main development directions of enterprises. In the future, with the continuous progress of technology and the expansion of application scenarios, the CAR - T cell service industry is expected to achieve greater development and bring more hope to patients with cancer and autoimmune diseases.
This report delivers a comprehensive overview of the global CAR-T Cell Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CAR-T Cell Service. The CAR-T Cell Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CAR-T Cell Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CAR-T Cell Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of CAR-T Cell Service Market Report

Report Metric Details
Report Name CAR-T Cell Service Market
Accounted market size in 2025 US$ 1443 million
Forecasted market size in 2032 US$ 2075 million
CAGR 5.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Development Services
  • Manufacturing Services
  • Other
Segment by Application
  • Clinical Research
  • Clinical Treatment
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec, ProMab Biotechnologies, Inc, Creative Biogene, BPS Bioscience, Inc, Reaction Biology, Cusabio Technology LLC, Oncodesign Services, ACROBiosystems, Kite Pharma, Inc, sartorius, WuXi ATU Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for CAR-T Cell Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is CAR-T Cell Service Market growing?

Ans: The CAR-T Cell Service Market witnessing a CAGR of 5.4% during the forecast period 2026-2032.

What is the CAR-T Cell Service Market size in 2032?

Ans: The CAR-T Cell Service Market size in 2032 will be US$ 2075 million.

Who are the main players in the CAR-T Cell Service Market report?

Ans: The main players in the CAR-T Cell Service Market are Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec, ProMab Biotechnologies, Inc, Creative Biogene, BPS Bioscience, Inc, Reaction Biology, Cusabio Technology LLC, Oncodesign Services, ACROBiosystems, Kite Pharma, Inc, sartorius, WuXi ATU Co

What are the Application segmentation covered in the CAR-T Cell Service Market report?

Ans: The Applications covered in the CAR-T Cell Service Market report are Clinical Research, Clinical Treatment, Other

What are the Type segmentation covered in the CAR-T Cell Service Market report?

Ans: The Types covered in the CAR-T Cell Service Market report are Development Services, Manufacturing Services, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Development Services
1.2.3 Manufacturing Services
1.2.4 Other
1.3 Market by Application
1.3.1 Global CAR-T Cell Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Research
1.3.3 Clinical Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Service Market Perspective (2021–2032)
2.2 Global CAR-T Cell Service Growth Trends by Region
2.2.1 Global CAR-T Cell Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 CAR-T Cell Service Historic Market Size by Region (2021–2026)
2.2.3 CAR-T Cell Service Forecasted Market Size by Region (2027–2032)
2.3 CAR-T Cell Service Market Dynamics
2.3.1 CAR-T Cell Service Industry Trends
2.3.2 CAR-T Cell Service Market Drivers
2.3.3 CAR-T Cell Service Market Challenges
2.3.4 CAR-T Cell Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cell Service Players by Revenue
3.1.1 Global Top CAR-T Cell Service Players by Revenue (2021–2026)
3.1.2 Global CAR-T Cell Service Revenue Market Share by Players (2021–2026)
3.2 Global Top CAR-T Cell Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by CAR-T Cell Service Revenue
3.4 Global CAR-T Cell Service Market Concentration Ratio
3.4.1 Global CAR-T Cell Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Service Revenue in 2025
3.5 Global Key Players of CAR-T Cell Service Head Offices and Areas Served
3.6 Global Key Players of CAR-T Cell Service, Products and Applications
3.7 Global Key Players of CAR-T Cell Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 CAR-T Cell Service Breakdown Data by Type
4.1 Global CAR-T Cell Service Historic Market Size by Type (2021–2026)
4.2 Global CAR-T Cell Service Forecasted Market Size by Type (2027–2032)
5 CAR-T Cell Service Breakdown Data by Application
5.1 Global CAR-T Cell Service Historic Market Size by Application (2021–2026)
5.2 Global CAR-T Cell Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America CAR-T Cell Service Market Size (2021–2032)
6.2 North America CAR-T Cell Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America CAR-T Cell Service Market Size by Country (2021–2026)
6.4 North America CAR-T Cell Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cell Service Market Size (2021–2032)
7.2 Europe CAR-T Cell Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe CAR-T Cell Service Market Size by Country (2021–2026)
7.4 Europe CAR-T Cell Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cell Service Market Size (2021–2032)
8.2 Asia-Pacific CAR-T Cell Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific CAR-T Cell Service Market Size by Region (2021–2026)
8.4 Asia-Pacific CAR-T Cell Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Cell Service Market Size (2021–2032)
9.2 Latin America CAR-T Cell Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America CAR-T Cell Service Market Size by Country (2021–2026)
9.4 Latin America CAR-T Cell Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cell Service Market Size (2021–2032)
10.2 Middle East & Africa CAR-T Cell Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa CAR-T Cell Service Market Size by Country (2021–2026)
10.4 Middle East & Africa CAR-T Cell Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aurigene Pharmaceutical Services Ltd
11.1.1 Aurigene Pharmaceutical Services Ltd Company Details
11.1.2 Aurigene Pharmaceutical Services Ltd Business Overview
11.1.3 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Introduction
11.1.4 Aurigene Pharmaceutical Services Ltd Revenue in CAR-T Cell Service Business (2021–2026)
11.1.5 Aurigene Pharmaceutical Services Ltd Recent Development
11.2 Cellipont Bioservices
11.2.1 Cellipont Bioservices Company Details
11.2.2 Cellipont Bioservices Business Overview
11.2.3 Cellipont Bioservices CAR-T Cell Service Introduction
11.2.4 Cellipont Bioservices Revenue in CAR-T Cell Service Business (2021–2026)
11.2.5 Cellipont Bioservices Recent Development
11.3 ProBio
11.3.1 ProBio Company Details
11.3.2 ProBio Business Overview
11.3.3 ProBio CAR-T Cell Service Introduction
11.3.4 ProBio Revenue in CAR-T Cell Service Business (2021–2026)
11.3.5 ProBio Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs CAR-T Cell Service Introduction
11.4.4 Creative Biolabs Revenue in CAR-T Cell Service Business (2021–2026)
11.4.5 Creative Biolabs Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories CAR-T Cell Service Introduction
11.5.4 Charles River Laboratories Revenue in CAR-T Cell Service Business (2021–2026)
11.5.5 Charles River Laboratories Recent Development
11.6 Cytiva
11.6.1 Cytiva Company Details
11.6.2 Cytiva Business Overview
11.6.3 Cytiva CAR-T Cell Service Introduction
11.6.4 Cytiva Revenue in CAR-T Cell Service Business (2021–2026)
11.6.5 Cytiva Recent Development
11.7 Sino Biological, Inc
11.7.1 Sino Biological, Inc Company Details
11.7.2 Sino Biological, Inc Business Overview
11.7.3 Sino Biological, Inc CAR-T Cell Service Introduction
11.7.4 Sino Biological, Inc Revenue in CAR-T Cell Service Business (2021–2026)
11.7.5 Sino Biological, Inc Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Details
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec CAR-T Cell Service Introduction
11.8.4 Miltenyi Biotec Revenue in CAR-T Cell Service Business (2021–2026)
11.8.5 Miltenyi Biotec Recent Development
11.9 ProMab Biotechnologies, Inc
11.9.1 ProMab Biotechnologies, Inc Company Details
11.9.2 ProMab Biotechnologies, Inc Business Overview
11.9.3 ProMab Biotechnologies, Inc CAR-T Cell Service Introduction
11.9.4 ProMab Biotechnologies, Inc Revenue in CAR-T Cell Service Business (2021–2026)
11.9.5 ProMab Biotechnologies, Inc Recent Development
11.10 Creative Biogene
11.10.1 Creative Biogene Company Details
11.10.2 Creative Biogene Business Overview
11.10.3 Creative Biogene CAR-T Cell Service Introduction
11.10.4 Creative Biogene Revenue in CAR-T Cell Service Business (2021–2026)
11.10.5 Creative Biogene Recent Development
11.11 BPS Bioscience, Inc
11.11.1 BPS Bioscience, Inc Company Details
11.11.2 BPS Bioscience, Inc Business Overview
11.11.3 BPS Bioscience, Inc CAR-T Cell Service Introduction
11.11.4 BPS Bioscience, Inc Revenue in CAR-T Cell Service Business (2021–2026)
11.11.5 BPS Bioscience, Inc Recent Development
11.12 Reaction Biology
11.12.1 Reaction Biology Company Details
11.12.2 Reaction Biology Business Overview
11.12.3 Reaction Biology CAR-T Cell Service Introduction
11.12.4 Reaction Biology Revenue in CAR-T Cell Service Business (2021–2026)
11.12.5 Reaction Biology Recent Development
11.13 Cusabio Technology LLC
11.13.1 Cusabio Technology LLC Company Details
11.13.2 Cusabio Technology LLC Business Overview
11.13.3 Cusabio Technology LLC CAR-T Cell Service Introduction
11.13.4 Cusabio Technology LLC Revenue in CAR-T Cell Service Business (2021–2026)
11.13.5 Cusabio Technology LLC Recent Development
11.14 Oncodesign Services
11.14.1 Oncodesign Services Company Details
11.14.2 Oncodesign Services Business Overview
11.14.3 Oncodesign Services CAR-T Cell Service Introduction
11.14.4 Oncodesign Services Revenue in CAR-T Cell Service Business (2021–2026)
11.14.5 Oncodesign Services Recent Development
11.15 ACROBiosystems
11.15.1 ACROBiosystems Company Details
11.15.2 ACROBiosystems Business Overview
11.15.3 ACROBiosystems CAR-T Cell Service Introduction
11.15.4 ACROBiosystems Revenue in CAR-T Cell Service Business (2021–2026)
11.15.5 ACROBiosystems Recent Development
11.16 Kite Pharma, Inc
11.16.1 Kite Pharma, Inc Company Details
11.16.2 Kite Pharma, Inc Business Overview
11.16.3 Kite Pharma, Inc CAR-T Cell Service Introduction
11.16.4 Kite Pharma, Inc Revenue in CAR-T Cell Service Business (2021–2026)
11.16.5 Kite Pharma, Inc Recent Development
11.17 sartorius
11.17.1 sartorius Company Details
11.17.2 sartorius Business Overview
11.17.3 sartorius CAR-T Cell Service Introduction
11.17.4 sartorius Revenue in CAR-T Cell Service Business (2021–2026)
11.17.5 sartorius Recent Development
11.18 WuXi ATU Co
11.18.1 WuXi ATU Co Company Details
11.18.2 WuXi ATU Co Business Overview
11.18.3 WuXi ATU Co CAR-T Cell Service Introduction
11.18.4 WuXi ATU Co Revenue in CAR-T Cell Service Business (2021–2026)
11.18.5 WuXi ATU Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global CAR-T Cell Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Development Services
 Table 3. Key Players of Manufacturing Services
 Table 4. Key Players of Other
 Table 5. Global CAR-T Cell Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global CAR-T Cell Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global CAR-T Cell Service Market Size by Region (US$ Million), 2021–2026
 Table 8. Global CAR-T Cell Service Market Share by Region (2021–2026)
 Table 9. Global CAR-T Cell Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global CAR-T Cell Service Market Share by Region (2027–2032)
 Table 11. CAR-T Cell Service Market Trends
 Table 12. CAR-T Cell Service Market Drivers
 Table 13. CAR-T Cell Service Market Challenges
 Table 14. CAR-T Cell Service Market Restraints
 Table 15. Global CAR-T Cell Service Revenue by Players (US$ Million), 2021–2026
 Table 16. Global CAR-T Cell Service Market Share by Players (2021–2026)
 Table 17. Global Top CAR-T Cell Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on CAR-T Cell Service Revenue, 2025
 Table 18. Ranking of Global Top CAR-T Cell Service Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by CAR-T Cell Service Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of CAR-T Cell Service, Headquarters and Area Served
 Table 21. Global Key Players of CAR-T Cell Service, Products and Applications
 Table 22. Global Key Players of CAR-T Cell Service, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global CAR-T Cell Service Market Size by Type (US$ Million), 2021–2026
 Table 25. Global CAR-T Cell Service Revenue Market Share by Type (2021–2026)
 Table 26. Global CAR-T Cell Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global CAR-T Cell Service Revenue Market Share by Type (2027–2032)
 Table 28. Global CAR-T Cell Service Market Size by Application (US$ Million), 2021–2026
 Table 29. Global CAR-T Cell Service Revenue Market Share by Application (2021–2026)
 Table 30. Global CAR-T Cell Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global CAR-T Cell Service Revenue Market Share by Application (2027–2032)
 Table 32. North America CAR-T Cell Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America CAR-T Cell Service Market Size by Country (US$ Million), 2021–2026
 Table 34. North America CAR-T Cell Service Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe CAR-T Cell Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe CAR-T Cell Service Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe CAR-T Cell Service Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific CAR-T Cell Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific CAR-T Cell Service Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific CAR-T Cell Service Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America CAR-T Cell Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America CAR-T Cell Service Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America CAR-T Cell Service Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa CAR-T Cell Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa CAR-T Cell Service Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa CAR-T Cell Service Market Size by Country (US$ Million), 2027–2032
 Table 47. Aurigene Pharmaceutical Services Ltd Company Details
 Table 48. Aurigene Pharmaceutical Services Ltd Business Overview
 Table 49. Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Product
 Table 50. Aurigene Pharmaceutical Services Ltd Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 51. Aurigene Pharmaceutical Services Ltd Recent Development
 Table 52. Cellipont Bioservices Company Details
 Table 53. Cellipont Bioservices Business Overview
 Table 54. Cellipont Bioservices CAR-T Cell Service Product
 Table 55. Cellipont Bioservices Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 56. Cellipont Bioservices Recent Development
 Table 57. ProBio Company Details
 Table 58. ProBio Business Overview
 Table 59. ProBio CAR-T Cell Service Product
 Table 60. ProBio Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 61. ProBio Recent Development
 Table 62. Creative Biolabs Company Details
 Table 63. Creative Biolabs Business Overview
 Table 64. Creative Biolabs CAR-T Cell Service Product
 Table 65. Creative Biolabs Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 66. Creative Biolabs Recent Development
 Table 67. Charles River Laboratories Company Details
 Table 68. Charles River Laboratories Business Overview
 Table 69. Charles River Laboratories CAR-T Cell Service Product
 Table 70. Charles River Laboratories Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 71. Charles River Laboratories Recent Development
 Table 72. Cytiva Company Details
 Table 73. Cytiva Business Overview
 Table 74. Cytiva CAR-T Cell Service Product
 Table 75. Cytiva Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 76. Cytiva Recent Development
 Table 77. Sino Biological, Inc Company Details
 Table 78. Sino Biological, Inc Business Overview
 Table 79. Sino Biological, Inc CAR-T Cell Service Product
 Table 80. Sino Biological, Inc Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 81. Sino Biological, Inc Recent Development
 Table 82. Miltenyi Biotec Company Details
 Table 83. Miltenyi Biotec Business Overview
 Table 84. Miltenyi Biotec CAR-T Cell Service Product
 Table 85. Miltenyi Biotec Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 86. Miltenyi Biotec Recent Development
 Table 87. ProMab Biotechnologies, Inc Company Details
 Table 88. ProMab Biotechnologies, Inc Business Overview
 Table 89. ProMab Biotechnologies, Inc CAR-T Cell Service Product
 Table 90. ProMab Biotechnologies, Inc Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 91. ProMab Biotechnologies, Inc Recent Development
 Table 92. Creative Biogene Company Details
 Table 93. Creative Biogene Business Overview
 Table 94. Creative Biogene CAR-T Cell Service Product
 Table 95. Creative Biogene Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 96. Creative Biogene Recent Development
 Table 97. BPS Bioscience, Inc Company Details
 Table 98. BPS Bioscience, Inc Business Overview
 Table 99. BPS Bioscience, Inc CAR-T Cell Service Product
 Table 100. BPS Bioscience, Inc Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 101. BPS Bioscience, Inc Recent Development
 Table 102. Reaction Biology Company Details
 Table 103. Reaction Biology Business Overview
 Table 104. Reaction Biology CAR-T Cell Service Product
 Table 105. Reaction Biology Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 106. Reaction Biology Recent Development
 Table 107. Cusabio Technology LLC Company Details
 Table 108. Cusabio Technology LLC Business Overview
 Table 109. Cusabio Technology LLC CAR-T Cell Service Product
 Table 110. Cusabio Technology LLC Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 111. Cusabio Technology LLC Recent Development
 Table 112. Oncodesign Services Company Details
 Table 113. Oncodesign Services Business Overview
 Table 114. Oncodesign Services CAR-T Cell Service Product
 Table 115. Oncodesign Services Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 116. Oncodesign Services Recent Development
 Table 117. ACROBiosystems Company Details
 Table 118. ACROBiosystems Business Overview
 Table 119. ACROBiosystems CAR-T Cell Service Product
 Table 120. ACROBiosystems Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 121. ACROBiosystems Recent Development
 Table 122. Kite Pharma, Inc Company Details
 Table 123. Kite Pharma, Inc Business Overview
 Table 124. Kite Pharma, Inc CAR-T Cell Service Product
 Table 125. Kite Pharma, Inc Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 126. Kite Pharma, Inc Recent Development
 Table 127. sartorius Company Details
 Table 128. sartorius Business Overview
 Table 129. sartorius CAR-T Cell Service Product
 Table 130. sartorius Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 131. sartorius Recent Development
 Table 132. WuXi ATU Co Company Details
 Table 133. WuXi ATU Co Business Overview
 Table 134. WuXi ATU Co CAR-T Cell Service Product
 Table 135. WuXi ATU Co Revenue in CAR-T Cell Service Business (US$ Million), 2021–2026
 Table 136. WuXi ATU Co Recent Development
 Table 137. Research Programs/Design for This Report
 Table 138. Key Data Information from Secondary Sources
 Table 139. Key Data Information from Primary Sources
 Table 140. Authors List of This Report


List of Figures
 Figure 1. CAR-T Cell Service Picture
 Figure 2. Global CAR-T Cell Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global CAR-T Cell Service Market Share by Type: 2025 vs 2032
 Figure 4. Development Services Features
 Figure 5. Manufacturing Services Features
 Figure 6. Other Features
 Figure 7. Global CAR-T Cell Service Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global CAR-T Cell Service Market Share by Application: 2025 vs 2032
 Figure 9. Clinical Research Case Studies
 Figure 10. Clinical Treatment Case Studies
 Figure 11. Other Case Studies
 Figure 12. CAR-T Cell Service Report Years Considered
 Figure 13. Global CAR-T Cell Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global CAR-T Cell Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global CAR-T Cell Service Market Share by Region: 2025 vs 2032
 Figure 16. Global CAR-T Cell Service Market Share by Players in 2025
 Figure 17. Global CAR-T Cell Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by CAR-T Cell Service Revenue in 2025
 Figure 19. North America CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America CAR-T Cell Service Market Share by Country (2021–2032)
 Figure 21. United States CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe CAR-T Cell Service Market Share by Country (2021–2032)
 Figure 25. Germany CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific CAR-T Cell Service Market Share by Region (2021–2032)
 Figure 33. China CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America CAR-T Cell Service Market Share by Country (2021–2032)
 Figure 41. Mexico CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa CAR-T Cell Service Market Share by Country (2021–2032)
 Figure 45. Israel CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE CAR-T Cell Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 49. Cellipont Bioservices Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 50. ProBio Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 51. Creative Biolabs Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 52. Charles River Laboratories Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 53. Cytiva Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 54. Sino Biological, Inc Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 55. Miltenyi Biotec Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 56. ProMab Biotechnologies, Inc Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 57. Creative Biogene Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 58. BPS Bioscience, Inc Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 59. Reaction Biology Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 60. Cusabio Technology LLC Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 61. Oncodesign Services Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 62. ACROBiosystems Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 63. Kite Pharma, Inc Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 64. sartorius Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 65. WuXi ATU Co Revenue Growth Rate in CAR-T Cell Service Business (2021–2026)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture